首页 › 期刊 › 医学 › European Journal of Gastroenterology & Hepatology
European Journal of Gastroenterology & Hepatology
出版商:Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins · ISSN:0954-691X, 1473-5687 · 国家/地区:US · 类型:journal · 官网:http://journals.lww.com/eurojgh/pages/default.aspx
研究主题:Liver Disease Diagnosis and Treatment · Liver Disease and Transplantation · Inflammatory Bowel Disease · Helicobacter pylori-related gastroenterology studies · Hepatitis C virus research
数据覆盖:9 个公开学术数据源交叉核验(crossref、fqb、jcr、openalex、scimago、wikidata、xr、cwts、jufo)。
数据来源与实体核验
期刊官网 · OpenAlex 期刊实体 · Wikidata 期刊实体 · Wikidata 英文名:European Journal of Gastroenterology and Hepatology
核心指标
- 影响因子(JCR 2025):2.100
- JCR 分区:Q3(GASTROENTEROLOGY & HEPATOLOGY)
- 中科院分区(2025):医学 4区,大类排名 3123/5603;小类:GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学 4区,排名 90/143
- 新锐分区(2026):医学 4区
- SJR:0.673(Q2),2025 年,United States
- CWTS 2025:SNIP 0.616 · IPP 2.076 · 自引率 1.2%
- JUFO 出版渠道等级:芬兰 1 · 挪威 1 · 丹麦 1
- h-index:131
- i10 指数:4597
- 近两年篇均被引:2.01
- 载文量 9564 · 总被引 190566
- Crossref DOI 总量:9469,近期 560
逐年趋势
- 近年影响因子:2021 2.59 → 2022 2.1 → 2023 2.3 → 2024 1.8 → 2025 2.1
- 近年 SJR:2021 0.685(Q2) → 2022 0.626(Q2) → 2023 0.698(Q2) → 2024 0.731(Q2) → 2025 0.673(Q2)
同学科期刊推荐
- CA-A CANCER JOURNAL FOR CLINICIANS — IF 685.2 · JCR Q1 · 中科院1区(Top)
- The Lancet — IF 109.0 · JCR Q1 · 中科院1区(Top)
- MMWR Surveillance Summaries — IF 96.9 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Clinical Oncology — IF 94.6 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Drug Discovery — IF 91.2 · JCR Q1 · 中科院1区(Top)
- New England Journal of Medicine — IF 84.5 · JCR Q1 · 中科院1区(Top)
- Signal Transduction and Targeted Therapy — IF 81.2 · JCR Q1 · 中科院1区(Top)
- Annals of Oncology — IF 80.4 · JCR Q1 · 中科院1区(Top)
常见问题
《European Journal of Gastroenterology & Hepatology》的影响因子是多少?
根据 JCR 2025 年数据,《European Journal of Gastroenterology & Hepatology》的最新影响因子(IF)为 2.100。
《European Journal of Gastroenterology & Hepatology》是几区期刊?
《European Journal of Gastroenterology & Hepatology》中科院分区(2025年版)为医学4区,JCR 分区为 Q3。
本刊近期代表论文
- Effect of high-intensity interval training on clinical parameters in patients with metabolic dysfunction–associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025 · 被引 6)
- Distinct composition and metabolic potential of biliary microbiota in patients with malignant bile duct obstruction (2025 · 被引 6)
- Autoimmune chronic atrophic gastritis: association between chronic proton pump inhibitors use and more severe atrophy and gastric intestinal metaplasia (2025 · 被引 4)
- Eosinophilic esophagitis is the leading cause of dysphagia in an outpatient setting (2025 · 被引 3)
- Accuracy of the American Society for Gastrointestinal Endoscopy, European Society of Gastrointestinal Endoscopy, and Society of American Gastrointestinal and Endoscopic Surgeons criteria in predicting common bile duct microlithiasis (2025 · 被引 3)
- CD96: immunoregulation and its role and prospect in immunotherapy of primary hepatocellular carcinoma (2025 · 被引 2)